Relationship of CYP2D6 status and toremifene metabolism

被引：1
|
作者：
Kim, J. [1 ]
Dalton, J. T. [1 ]
Veverka, K. A. [1 ]
机构：
[1] GTx Inc, Memphis, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e13068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13068
引用
收藏
页数：1
相关论文
共 50 条
  • [11] A novel CYP2D6 scoring system for the prediction of CYP2D6 activity: Application to tamoxifen metabolism.
    Borges, S.
    Li, L.
    Robarge, J.
    Nguyen, A.
    Azzouz, F.
    Desta, Z.
    Skaar, T.
    Flockhart, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S67 - S67
  • [12] Olanzapine metabolism by CYP1A2/CYP2D6 and hyperglycaemia
    Iwahashi, K
    ACTA NEUROPSYCHIATRICA, 2004, 16 (04) : 229 - 230
  • [13] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [14] CYP2D6, serotonin, and suicide-a relationship?
    Bertilsson, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 304 - 305
  • [15] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
  • [16] Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol
    Fang, J
    Baker, GB
    Silverstone, PH
    Coutts, RT
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1997, 17 (02) : 227 - 233
  • [17] Involvement of CYP3A4 and CYP2D6 in the Metabolism of Haloperidol
    Jian Fang
    Glen B. Baker
    Peter H. Silverstone
    Ronald T. Coutts
    Cellular and Molecular Neurobiology, 1997, 17 : 227 - 233
  • [18] Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
    Livezey, Mara R.
    Briggs, Erran D.
    Bolles, Amanda K.
    Nagy, Leslie D.
    Fujiwara, Rina
    Furge, Laura Lowe
    XENOBIOTICA, 2014, 44 (04) : 309 - 319
  • [19] Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR
    Hersberger, M
    Marti-Jaun, J
    Rentsch, K
    Hänseler, E
    CLINICAL CHEMISTRY, 2000, 46 (08) : 1072 - 1077
  • [20] CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical Relevance
    Higgins, Michaela J.
    Stearns, Vered
    CURRENT ONCOLOGY REPORTS, 2010, 12 (01) : 7 - 15
12345